Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.3900 (0.41%) ($7.3900 - $7.3900) on Tue. Sep. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 59 | Latest Price | $7.3900(0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UUP(72%) TBT(31%) EWJ(30%) VXX(33%) IDRV(49%) | Factors Impacting BCRX price | BCRX will decline at least -1.64% in a week (0% probabilities). SIL(-78%) VT(-70%) PEJ(-61%) VYM(-55%) ICLN(-47%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.29(1.37%) | 10 Day Moving Average | $7.24(2.07%) | 20 Day Moving Average | $7.14(3.5%) | To recent high | -6.3% | To recent low | 10.3% | Market Cap | $1.304b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |